Key facts
| Price (PPV) | 7,394 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | palipéridone |
| Class | Psycholeptics (antipsychotics, anxiolytics, hypnotics) |
| ATC code | N05AX13 |
| Manufacturer | MAPHAR |
| Presentation | Boite d'une seringue pré-remplie et 2 aiguilles |
| Hospital price | 7,200 MAD |
| Data collected on | 9/8/2026 |
Indications
Trevicta, une forme galénique injectable trimestrielle de palmitate de palipéridone, est indiqué dans le traitement de la schizophrénie chez les patients adultes traités depuis au moins quatre mois de manière appropriée avec la forme galénique injectable mensuelle de palmitate de palipéridone.
Psychoactive substance / dependence
Oui
Find an open pharmacy
On-call pharmacies near you
About Trevicta 263 mg
Trevicta 263 mg belongs to the psycholeptics (antipsychotics, anxiolytics, hypnotics) therapeutic class. In Morocco, this drug is marketed by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Trevicta 263 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Trevicta 263 mg
Answers to common questions from Moroccan patients about this drug.